In the SWI/SNF chromatin remodelling complex, a mutated AT-rich interaction domain 1A (ARID1A) subunit is enriched in metastatic ERα-positive breast cancers which are no longer responsive to endocrine therapy (Razavi et al., 2018; Xu et al., 2020). The gene discussed is ARID1A; the disease is breast cancer.